-
Mashup Score: 18Genentech: Press Releases | Wednesday, Dec 18, 2024 - 13 day(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 7Genentech: Press Releases | Friday, Oct 18, 2024 - 2 month(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, PayerTweet-
#Breaking: Positive results from the ELEVATUM study showed that our approved treatment for diabetic macular edema improved vision in patients from underrepresented populations. Read more about this groundbreaking study: https://t.co/rX96pFMCay #AAO2024 #DiabeticEyeDisease https://t.co/e8ptnXL5XK
-
-
Mashup Score: 6Genentech: Press Releases | Sunday, Oct 13, 2024 - 3 month(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, PayerTweet-
#Breaking: During #WMS2024, we presented two-year data assessing the efficacy and safety of our medicine for spinal muscular atrophy (#SMA) in children treated pre-symptomatically before six weeks of age. Learn more: https://t.co/2fnQSJ9vfD https://t.co/hzemyoJX67
-
-
Mashup Score: 27Genentech: Press Releases | Thursday, Oct 10, 2024 - 3 month(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, PayerTweet-
#Breaking: @US_FDA approved our treatment regimen for people with PIK3CA-mutated, advanced HR+/HER2- #breastcancer, offering a new option to target PIK3CA, one of the most commonly mutated genes in #metastaticbreastcancer. Learn more: https://t.co/EJJnnrccLB https://t.co/NW1lfcLICV
-
-
Mashup Score: 6Genentech: Press Releases | Sunday, Oct 13, 2024 - 3 month(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, PayerTweet-
#Breaking: During #WMS2024, we presented two-year data assessing the efficacy and safety of our medicine for spinal muscular atrophy (#SMA) in children treated pre-symptomatically before six weeks of age. Learn more: https://t.co/2fnQSJ9vfD https://t.co/hzemyoJX67
-
-
Mashup Score: 25Genentech: Press Releases | Thursday, Oct 10, 2024 - 3 month(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, PayerTweet-
#Breaking: @US_FDA approved our treatment regimen for people with PIK3CA-mutated, advanced HR+/HER2- #breastcancer, offering a new option to target PIK3CA, one of the most commonly mutated genes in #metastaticbreastcancer. Learn more: https://t.co/EJJnnrccLB https://t.co/NW1lfcLICV
-
-
Mashup Score: 7Genentech: Press Releases | Wednesday, Sep 25, 2024 - 3 month(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, PayerTweet-
#Breaking: Today we announced positive topline Phase III results in lupus nephritis for our monoclonal antibody targeting CD20, a protein found on certain types of B cells. Learn more: https://t.co/JoZZ5qfjdo https://t.co/MrdpnekWPt
-
-
Mashup Score: 0Genentech: Press Releases | Wednesday, Sep 18, 2024 - 3 month(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, PayerTweet-
#Breaking: Today, we announced positive topline study results evaluating one of our antivirals in the transmission of influenza viruses. Learn more: https://t.co/QL9eBmYJPg https://t.co/t2gODUF10J
-
-
Mashup Score: 26Genentech: Press Releases | Thursday, Sep 12, 2024 - 4 month(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, PayerTweet-
#Breaking: Our #immunotherapy is now the first FDA-approved subcutaneous PD-(L)1 inhibitor available to cancer patients in the US. Learn more: https://t.co/fn5fC6DzAA https://t.co/5PZNjUFn9a
-
-
Mashup Score: 14Genentech: Press Releases | Friday, Sep 13, 2024 - 4 month(s) ago
Discover the latest news about our company, our products, our policies, and our people.
Source: www.gene.comCategories: General Medicine News, PayerTweet-
#Breaking: The @US_FDA has granted approval for our subcutaneous injection for the treatment of adults with relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS). Learn more: https://t.co/3xdX3JkFkK https://t.co/X1sWLsHryX
-
#Breaking: Today we announced results from our Phase IIb study in early Parkinson’s, a progressive neurological disorder. Learn more: https://t.co/LEr1qtQe3c #Parkinsons